Skip to content

24/7 dementia helpline 800-272-3900

Dementia Today

Uncovering first molecular missteps that drive neurons in pathway leading to Alzheimer’s disease

Dementia TodayPublished December 16, 20134 min read

Key points

  • Much of the debate in Alzheimer’s disease (AD) has focused on whether the protein amyloid-beta or the tau protein is the symptom or the cause of the disease.
  • Bloom will present additional evidence supporting the role of CCR in AD on Sunday, Dec.
  • These new findings are scientific sequels to a series of dramatic discoveries by the Dr.
  • Bloom said that he views AD as fundamentally a problem of the cell cycle, with both amyloid-beta and tau required for the interaction that pushes neurons into destructive CCR.

Much of the debate in Alzheimer’s disease (AD) has focused on whether the protein amyloid-beta or the tau protein is the symptom or the cause of the disease.

But George Bloom, Ph.D., and colleagues at the University of Virginia (UVA) have pursued another hypothesis: much earlier interactions between the two proteins them drive adult neurons into the forbidden pathway of “cell cycle re-entry” (CCR).

Dr. Bloom will present additional evidence supporting the role of CCR in AD on Sunday, Dec. 15, at the American Society for Cell Biology (ASCB) annual meeting in New Orleans. He will report the identification of a critical balance point between tau and a master cellular regulator that amyloid-beta oligomers disrupt.

A novel group of proteins, Rac1, Gαs (Gs alpha) and NCAM, and two protein kinase complexes, mTORC1 and mTORC2, play a role in driving mature neurons to their death, according to the UVA researchers.

These new findings are scientific sequels to a series of dramatic discoveries by the Dr. Bloom’s lab that unravel the molecular events that drive adult neurons in CCR. As Dr. Bloom noted in his research presentation at last year’s ASCB annual meeting, most normal adult neurons are supposed to be permanently post-mitotic – that is, they have finished dividing and are locked out of the cell cycle.

Yet in AD, neurons frequently re-enter the cell cycle, fail to complete mitosis and ultimately die. In late stage AD, up to 30 percent of the neurons in the frontal lobes of the brain are dead, surrounded by large amyloid plaques and tau-associated neurofibrillary tangles.

Dr. Bloom said that he views AD as fundamentally a problem of the cell cycle, with both amyloid-beta and tau required for the interaction that pushes neurons into destructive CCR. “The massive neuron death that occurs in AD therefore appears to be caused by the raw ingredients of plaques and tangles working in concert with each other, rather than by the plaques and tangles themselves,” Dr. Bloom explained.

This new research to be presented at ASCB 2013 follows up on results published last spring when the UVA researchers described in greater detail how amyloid-beta activates multiple enzymes named protein kinases to add phosphates to specific sites on tau, setting neurons on the pathway to CCR.

Now in this new molecular “sequel,” Dr. Bloom and lab members Andrés Norambuena and Lloyd McMahon implicate a novel group of proteins – Rac1, Gαs (Gs alpha), and NCAM – and two protein kinases complexes – mTORC1 and mTORC2 – as required participants to set off CCR.

Their identification reveals how a fundamental balance is upset, placing neurons on the road to AD. “The mTOR complexes are master regulators of cellular proliferation, growth and metabolism,” Dr. Bloom said. “Most important, our results indicate that tau normally inhibits mTOR from promoting neuronal cell replication, but that this inhibition is reversed by an amyloid beta oligomer-induced, mTOR-dependent mechanism that modifies tau. In other words, tau and mTOR regulate each other.”

This delicate balance is compromised by amyloid-beta oligomers in a way that allows neurons that should never replicate to re-enter the cell cycle. They fail to divide and eventually die instead. “Some of the earliest events in AD pathogenesis are therefore caused by amyloid-beta oligomers altering a fundamental neuronal signaling axis centered around tau and mTOR,” proposed Dr. Bloom who said that he believes that the proteins identified in this signaling axis are potential biomarkers, and therapeutic targets for very early stages of AD, leaving the door open for an even more exciting sequel down the road.

###

The research was supported by the Owens Family Foundation, Alzheimer’s Association and a National Institute of General Medical Sciences training grant.

CONTACT:

George S. Bloom, Ph.D.
University of Virginia
Charlottesville, VA
434-243-3543
Gsb4g@virginia.edu

ASCB PRESS CONTACTS:

John Fleischman
jfleischman@ascb.org
513-706-0212

Cathy Yarbrough
Cyarbrough@ascb.org
858-243-1814

Author will present, “Ectopic Cell Cycle Re-entry, a Major Cause of Neuron Death in Alzheimer’s Disease Is Controlled by Rac1 and mTOR,” Sunday, Dec. 15, 2013, during the 12 noon to 1:30 p.m. poster session, “Rho-Family GTPases.”

Co-authors are: A. Norambuena, L. McMahon, E. Kodis and G.S. Bloom of UVA.

###

Cathy Yarbrough
cyarbrough@ascb.org
858-243-1814

John Fleischman
jfleischman@ascb.org

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. If a person with dementia is missing, injured or in danger, call 911 or your local emergency number.

Filed underDementia News

Worried about memory changes?

Normal aging, or an early warning sign?

Ten common changes, each set beside what is typical with age. Tick what you have noticed and see what to do next.

Open the 10-sign checklist

Getting help

Sudden changes are not just the dementia.

Dementia usually changes slowly. A sharp change over hours or days can mean an infection, delirium, a stroke or a medication problem, and needs a doctor the same day. Call 911 or your local emergency number if you see any of these:

  • Confusion that comes on suddenly, over hours or days
  • Face drooping, arm weakness or slurred speech
  • A fall, a head injury or new severe pain
  • Very drowsy or hard to wake

The free Alzheimer’s Association Helpline answers questions about memory loss, diagnosis and caregiving, day and night, in more than 200 languages (US).

If someone with dementia is missing

  1. STEP 115 minSearch close by firstCheck the house, garden, car and the places the person often walks to. Don’t spend longer than about 15 minutes.
  2. STEP 2911Then call for helpTell the operator the person has dementia and is a vulnerable adult. Police treat this as urgent.
  3. STEP 3PhotoHave details readyA recent photo, what they were wearing, medical conditions and places they used to live or work.

Based on Alzheimer’s Association guidance on wandering. Outside the US, call your local emergency number.